Global (AMER, APAC, BRICS and EMEA) Nuclear Medicine/Radiopharmaceuticals Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

  • TBI579778
  • November 11, 2019
  • Global
  • 134 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Nuclear Medicine/Radiopharmaceuticals Market

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged-for example, positronemitting radiopharmaceuticals. Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine. In 2019, the market size of Nuclear Medicine/Radiopharmaceuticals is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Medicine/Radiopharmaceuticals. This report studies the global market size of Nuclear Medicine/Radiopharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Nuclear Medicine/Radiopharmaceuticals sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

Market Segmentation, Outlook & Regional Insights: Nuclear Medicine/Radiopharmaceuticals Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025: Diagnostic Therapeutic Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025: Oncology Thyroid Cardiology

Key Players, Recent Developments & Sector Viewpoints: Nuclear Medicine/Radiopharmaceuticals Market

China Isotope & Radiation Dongcheng Jaco Ciaeriar Advanced Molecular-imaging Solution Shanghai Atom Kexing

Key Insights Covered: Exhaustive Nuclear Medicine/Radiopharmaceuticals Market

1. Market size (sales, revenue and growth rate) of Nuclear Medicine/Radiopharmaceuticals industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Nuclear Medicine/Radiopharmaceuticals industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Nuclear Medicine/Radiopharmaceuticals industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Nuclear Medicine/Radiopharmaceuticals industry.

Research Methodology: Nuclear Medicine/Radiopharmaceuticals Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type

1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type (2019-2025)

1.3.2 Diagnostic

1.3.3 Therapeutic
1.4  

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2019-2025)

1.4.2 Oncology

1.4.2 Thyroid

1.4.2 Cardiology
1.5 Study Objectives
1.6 Years Considered2 Global Growth Trends
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size

2.1.1 Global Nuclear Medicine/Radiop
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form